Source: GlobeNewswire

Press Release: Paratek : Paratek Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference

BOSTON, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today announced that the Company will present at 21st Annual H.C. Wainwright Global Investment Conference on Monday, September 9 at 11:15 a.m. ET at the Lotte New York Palace Hotel in New York.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Evan Loh's photo - CEO of Paratek

CEO

Evan Loh

CEO Approval Rating

90/100

Paratek is a biopharmaceutical company that develops antibiotic drugs to treat bacterial pneumonia in adults. Read more